Walgreens (WAG) Reports Q3 EPS of $0.53; Comps Rose 2.8%
More News related to WAG
- Highmark to Open Two Worksite Health Centers at Company Facilities
- Walgreens to Offer H1N1 Vaccine in Salt Lake City Area, Partnering with Local Government in County-Wide Inoculation Effort
- Walgreens CFO to Speak at Upcoming Healthcare Conference
- Walgreens October Sales Increase 9.4 Percent
- Walgreens to Host Diabetes Wellness Clinics with Free Testing at In-Store Events Nationwide
Walgreens (NYSE: WAG) (NASDAQ: WAG) reports Q3 EPS of $0.53, (including an impact of 6 cents in costs and 6 cents in savings associated with the company's Rewiring for Growth and Customer Centric Retailing initiatives) versus the analyst estimate of $0.56. Revenue for the quarter was $16.21 billion, versus the consensus of $16.16 billion.
Same store sales rose 2.8% during the quarter.
UPDATE: Click here to see some highlights from the company's Q3 conference call.
Related Categories
EarningsRetail Sales
Stocks Mentioned
-0.50Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
